Skip to main content

Table 1 Patients’ characteristics

From: Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer

Characteristics

Number (%) / Median (range)

Age

  

57 (19–86)

FIGO

 

I

 

42 (25%)

II

 

10 (5.95%)

III

 

103 (61.31%)

IV

 

13 (7.74%)

Histology

  

Serous

 

124 (73.81%)

Endometrioid

 

18 (10.72%)

Clear cell

 

10 (5.95%)

Mucinous

 

4 (2.38%)

Nondifferentiated

 

4 (2.38%)

Mixed

 

8 (4.76%)

Grade

  

1

 

16 (9.52%)

2

 

35 (20.83%)

3

 

117 (69.65%)

Cytoreduction

  

R0

 

116 (69.05%)

R1 (≤ 1 cm)

 

29 (17.26%)

R2 (>  1 cm)

 

23 (13.69%)

Neoadjuvant chemotherapy

  

26 (15.48%)

Bevacizumab

  

32 (19.05%)

CA-125 before therapy

  

229.20 U/ml

(3.80–6000 U/ml)

Nadir CA-125 after therapy

  

10 U/ml

(2.70–35 U/ml)